Soybean and Hyperphosphataemia - a phase IV clinical study of FDA data

Summary:

Hyperphosphataemia is reported as a side effect among people who take Soybean (soy), especially for people who are male, 60+ old, also take Metronidazole, and have Ventricular fibrillation.

The phase IV clinical study analyzes which people have Hyperphosphataemia when taking Soybean. It is created by eHealthMe based on reports of 223 people who have side effects when taking Soybean from the FDA, and is updated regularly.

What is Soybean?

Soybean has active ingredients of soy. eHealthMe is studying from 224 Soybean users. Check the latest studies of Soybean.

What is Hyperphosphataemia?

Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood) is found to be associated with 429 drugs and 377 conditions by eHealthMe. Check the latest studies of Hyperphosphataemia.

On Jul, 24, 2026

223 people reported to have side effects when taking Soybean.
Among them, 12 people (5.38%) have Hyperphosphataemia.

Among these 12 people:

What is the gender of people who have Hyperphosphataemia when taking Soybean? *

female: 0.0 %
male: 100 %

What is the age of people who have Hyperphosphataemia when taking Soybean? *

What are other drugs people take besides Soybean? *

Lansoprazole: 12 people, 100.00%
Simvastatin: 12 people, 100.00%
Allopurinol: 12 people, 100.00%
Aranesp: 12 people, 100.00%
Atrovent: 12 people, 100.00%
Biotin: 12 people, 100.00%
Gabapentin: 12 people, 100.00%
Hydromorphone Hydrochloride: 12 people, 100.00%
Lutein: 12 people, 100.00%
Metronidazole: 12 people, 100.00%

What are other side effects people have besides Hyperphosphataemia? *

Iron Deficiency: 12 people, 100.00%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 12 people, 100.00%
Thrombosis (formation of a blood clot inside a blood vessel): 11 people, 91.67%
Death: 11 people, 91.67%
Anaemia (lack of blood): 11 people, 91.67%
Pulmonary Embolism (blockage of the main artery of the lung): 11 people, 91.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 11 people, 91.67%
Diabetes: 10 people, 83.33%
Dyspnea (difficult or laboured breathing): 10 people, 83.33%
General Physical Health Deterioration (weak health status): 10 people, 83.33%

What are the existing conditions these people have? *

High Blood Cholesterol: 12 people, 100.00%
Nausea (feeling of having an urge to vomit): 12 people, 100.00%
Bacterial Infection: 12 people, 100.00%
Blood Phosphorus Increased: 12 people, 100.00%
Blood Uric Acid Increased: 12 people, 100.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 12 people, 100.00%
Constipation: 12 people, 100.00%
Diabetes: 12 people, 100.00%
Dyspnea (difficult or laboured breathing): 12 people, 100.00%
Ventricular Fibrillation (abnormally irregular heart rhythm): 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Soybean and have Hyperphosphataemia?

- Check whether Hyperphosphataemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Soybean:

Soybean (224 reports)

Browse all side effects of Soybean:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperphosphataemia:

Hyperphosphataemia (430 drugs)

Browse all the conditions that are associated with Hyperphosphataemia:

Hyperphosphataemia (377 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on soy (the active ingredients of Soybean) and Soybean (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.